Advisory Services Network’s Ocular Therapeutix OCUL Stock Holding History

Advisory Services Network’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.26M	Buy	230,454 +91,557	+66%	+$830K	0.03%	656
2026 Q1	$1.18M	Buy	+138,897	New	+$1.32M	0.02%	852
2025 Q4	–	Sell	-636	Closed	-$7.43K	–	3468
2025 Q3	$7.43K	Buy	+636	New	+$7.61K	﹤0.01%	3394
2023 Q2	–	Sell	-250	Closed	-$1.32K	–	2913
2023 Q1	$1.32K	Hold	250	–	–	﹤0.01%	3554
2022 Q4	$703	Buy	+250	New	+$828	﹤0.01%	3674
2021 Q3	–	Sell	-250	Closed	-$4K	–	2631
2021 Q2	$4K	Buy	+250	New	+$3.8K	﹤0.01%	3151
2021 Q1	–	Sell	-250	Closed	-$5K	–	2429
2020 Q4	$5K	Hold	250	–	–	﹤0.01%	2724
2020 Q3	$2K	Buy	+250	New	+$2.08K	﹤0.01%	3149
2018 Q2	–	Sell	-288	Closed	-$2K	–	2629
2018 Q1	$2K	Hold	288	–	–	﹤0.01%	2390
2017 Q4	$1K	Hold	288	–	–	﹤0.01%	2466
2017 Q3	$2K	Hold	288	–	–	﹤0.01%	2168
2017 Q2	$3K	Hold	288	–	–	﹤0.01%	2016
2017 Q1	$3K	Buy	+288	New	+$2.4K	﹤0.01%	1893
2016 Q3	$3K	Sell	460 -89	-16%	-$542	﹤0.01%	1688
2016 Q2	$3K	Hold	549	–	–	﹤0.01%	1567
2016 Q1	$5K	Hold	549	–	–	﹤0.01%	1272
2015 Q4	$5K	Buy	+549	New	+$5.93K	﹤0.01%	1144

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Advisory Services Network's OCUL Position: Q2 2026 in Review

Advisory Services Network increased its Ocular Therapeutix (OCUL) stake by 66% in Q2 2026, buying an estimated $830K and bringing the position to 230,454 shares worth $2.26M. The position accounts for 0.03% of the portfolio, ranked #656.

Advisory Services Network first reported a position in OCUL in Q4 2015 and has held it in 17 quarters since. 263 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

Advisory Services Network held 230,454 shares of Ocular Therapeutix worth $2.26M as of Q2 2026.
Advisory Services Network bought 91,557 Ocular Therapeutix shares in Q2 2026, an estimated $830K.
Ocular Therapeutix made up 0.03% of Advisory Services Network's portfolio in Q2 2026, its #656 holding.
Advisory Services Network first reported a position in Ocular Therapeutix in Q4 2015 and has held it in 17 quarters since.
263 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.